Synthesis, characterization, and cytotoxicity analyses of ABA-type block copolymer bearing p-xylene-bis(2-mercaptoethyloxy) core
Abstract
ABA–type amphiphilic novel poly(N-vinyl pyrrolidone)-block-poly(D,L-lactide)-block-poly(N-vinyl pyrrolidone) (PNVP-b-PDLLA-b-PNVP), triblock copolymer was synthesized via combination of ring-opening polymerization (ROP) and reversible addition-fragmentation chain transfer (RAFT) polymerization using novel bifunctional PDLLA based RAFT macro chain transfer agent (CTA) bearing p-xylene-bis(2-mercaptoethyloxy) core. For this goal, bifunctional initiator p-xylene-bis-(1-hydroxy-3-thia-propane) (1) was synthesized by the reaction of α,α'-dibromo-p-xylene with 2-mercaptoethanol in the presence of KOH in ethanol. PDLLA-diol was synthesized by metal-free organocatalyzed ROP of D, L-lactide (D,L-LA) in presence of 4-(dimethylamino) pyridine (DMAP) as catalyst using (1) as initiator Dibromoester end-functionalized PDLLA-based macroinitiator (3) was prepared by esterification of hydroxyl end groups of PDLLA-diol (2). PDLLA macro-CTA (4) was then synthesized via a substitution reaction of (3) with potassium ethylxanthate (KEX). Finally, PNVP-b-PDLLA-b-PNVP triblock copolymer (5) was synthesized RAFT polymerization of NVP using (4). Characterization of the molecular structures for synthesized novel polymers was made by spectroscopic (FTIR, 1H NMR) methods. In this study's application phase, polymers' effectiveness was examined on cervical cancer cells. Cytotoxicity and metastatic effects were evaluated in vitro on HeLa cell lines. In our study, we observed no toxic effect of the block copolymer below 600 µg/mL on the HeLa cervical cancer cell line and in future studies on drug delivery studies of cancer treatments.
Keywords
Amphiphilic block copolymer, Cytotoxicity, Cancer cells
Project Number
MMF.A3.24.005
Thanks
This study was supported by Kırşehir Ahi Evran University Scientific Research Projects Unit, Grant number: MMF.A3.24.005.
References
- S. Rawal, M. M. Patel, Threatening cancer with nanoparticle aided combination oncotherapy, Journal of Controlled Release. 301 (2019) 76-109.
- L. Zhao, N. Li, K. Wang, C. Shi, L. Zhang, Y. Luan, A review of polypeptide-based polymersomes, Biomaterials 35 (4) (2014) 1284-1301.
- T. Biela, A. Kowalski, J. Libiszowski, A. Duda, S. Penczek, Progress in polymerization of cyclic esters: mechanisms and synthetic applications, Macromolecular symposia 240 (1) (2006) 47-55.
- D. Babikova, R. Kalinova, I. Zhelezova, D. Momekova, S. Konstantinov, G. Momekov, D. Ivaylo, Functional block copolymer nanocarriers for anticancer drug delivery, RSC Advances 6 (88) (2016) 84634-84644.
- T. K. Dash, V. B. Konkimalla, Polymeric modification and its implication in drug delivery: Poly-ε-caprolactone (PCL) as a model polymer, Molecular Pharmaceutics 9 (9) (2012) 2365-2379.
- M. Hussain, S. M. Khan, M. Shafiq, N. Abbas, A review on PLA-based biodegradable materials for biomedical applications, Giant 18 (2024) Article Number 100261 31 pages.
- C-F. Yu, S-P. Rwei, S-J. Yang, W-C. Tsen, L-H. Lin, Synthesis and characterization of poly (DL-lactide) containing fluorene structures, Polymers 15 (11) (2023) Article Number 2555 16 pages.
- P. Franco, I. De Marco, The use of poly (N-vinyl pyrrolidone) in the delivery of drugs: A review, Polymers 12 (5) (2020) Article Number 1114 29 pages.
- D. Gigmes, T. Trimaille, Advances in amphiphilic polylactide/vinyl polymer based nano-assemblies for drug delivery, Advances in Colloid and Interface Science 294 (2021) Article Number 102483 13 pages.
- D. Le Garrec, S. Gori, L. Luo, D. Lessard, D. C. Smith, M.-A. Yessine, M. Ranger, J-C. Leroux, Poly (N-vinylpyrrolidone)-block-poly (D, L-lactide) as a new polymeric solubilizer for hydrophobic anticancer drugs: in vitro and in vivo evaluation, Journal of Controlled Release 99 (1) 2004 83-101.